A summary of safety of gadofosveset (MS-325) at 0.03 mmol/kg body weight dose: Phase II and Phase III clinical trials data. [electronic resource]

By: Contributor(s): Producer: 20080403Description: 822-30 p. digitalISSN:
  • 0020-9996
Subject(s): Online resources: In: Investigative radiology vol. 41
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.